1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021)
 

Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021) -– (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK, Germany, India, Japan, China, Brazil, UAE; Stents – Pipeline Analysis)

 
Publish Date:November 2016
No. of Pages:158
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$2200
 
Electronic Access - Multi User License toll
$3000
 
Hard Copy Mail Delivery toll
$2400
 
 

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research,the report aims to present the analysis of global coronary stent market on the basis of Segments (Bare Metal stents or BMS, Drug-Eluting Stents or DES and Bioresorbable Stents), By Region (North America, Europe, APAC and ROW)and By Country (USA, Canada,UK, Germany, India, Japan, China, Brazil, UAE).

Rising development of bioresorbable stents combined with the growing awareness towards cardiovascular risks in developing countries has resulted in the growth of coronary stents market. Cardiovascular diseases are witnessing growth on account of the rise in the lifestyle related diseases including obesity,diabetes, hypertension etc.

Among the types of coronary stents, market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue while bare metal stents will further continue to decline.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population.

Global Coronary Stents Market is forecasted to grow at a CAGR of 3.05% during 2016 – 2021F, on account of rising incidences of cardiovascular diseases globally leading to growing number of stent procedures.

The North American region remains the major market followed by Europe in the actual period, while APAC and ROW will witness strong growth in the forecast period.

According to Azoth Analytics research report, Global Coronary Stents (Bare Metal,Drug-Eluting, Bioresorable) Market: Analysis By Segment, By Region, By Country(2016-2021) – (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK,Germany, India, Japan, China,  Brazil, UAE), Global Coronary Stents market is projected to exhibit a CAGR of over ~3.05%during 2016 - 2021. On the basis of market segment, Global Coronary Stents Markethas been segmented as Bare Metal stents (BMS), Drug-ElutingStents (DES) and Bioresorbable Stents; analysed by Regions-North America, Europe, APAC, ROW and by Country - USA, Canada, UK,Germany, India, Japan, China,  Brazil, UAE.

 

Scope of theReport

The report provides Segmentation by Stent Type

  •         Bare Metal stents 

  •          Drug-Eluting Stents

  •          Bioresorbable Stents

The report provides coverage by Region

  •          North America

  •          Europe

  •          Asia Pacific

  •          ROW

The report provides coverage by Country

  •          USA

  •          Canada

  •          UK

  •          Germany

  •          India

  •          Japan

  •          China

  •          Brazil

  •          UAE

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.  

Table of Content

 

1. Research Methodology             

 

2. Executive Summary                                                                  

 

3. Strategic Recommendations

3.1. Bioresorbable Stents asthe Future Market

3.2. Focus on Lowering of ASP in Coronary Stents

3.3. Opportunities in APAC Region

 

4. Global Coronary Stents Market: An Analysis

 

4.1. Product Overview

4.2. Global Coronary Stents Market

4.2.1.  By Value (Historic 2011-15)

4.2.2.  By Value ( Forecast 2016E-2021F)

4.3.  Global Coronary Stent Market, By Segments

4.3.1.  In Percentage (2015)

4.3.2.  In Percentage (2021F)

4.4.  Global Bare Metal Stents, By Value

4.4.1.  By Value (Historic 2011-15)

4.4.2.  By Value (Forecast 2016E-2021F)

4.5.  Global Drug Eluting Stents, By Value

4.5.1.  By Value (Historic 2011-15)

4.5.2.  By Value ( Forecast 2016E-2021F)

4.6.  Global Bioresorbable Stents Market, By Segments

4.6.1.  By Value (Historic 2011-15)

4.6.2.  By Value ( Forecast 2016E-2021F)

4.7.  Global Coronary Stent Market, By Region

4.7.1.  In Percentage (2015)

4.7.2.  In Percentage (2021F)

4.8.  Coronary Stents:Pipeline Analysis

 

5. North America Coronary Stent Market: An Analysis

5.1 North America Coronary Stent Market, By Value

5.1.1.  By Value (Historic 2011-15)

5.1.2.  By Value (Forecast 2016E-2021F)

5.2 North America Bare Metal Stent Market , By Value

5.2.1.  By Value (Historic 2011-15)

5.2.2.  By Value ( Forecast 2016E-2021F)

5.3 North America Drug Eluting Stent Market , By Value

5.3.1.  By Value (Historic 2011-15)

5.3.2.  By Value ( Forecast 2016E-2021F)

5.4 North America Bioresorbable Stent Market , By Value

5.4.1.  By Value ( 2011-2021F)

5.5 North America Coronary Stent Market, By Country , By Percentage

5.5.1.  In Percentage (2015)

5.5.2.  In Percentage (2021F)

5.6 North America Coronary Stent Market, By Country (USA,Canada) (2011-2021F)

5.6.1. USA Coronary Stents Market, By Value

5.6.1.1 By Value (2011-2021F)

5.6.2   Canada  Coronary Stents Market, By Value

5.6.2.1. By Value (2011-2021F)

 

6. Europe Coronary Stent Market: An Analysis

6.1 Europe Coronary Stent Market , By Value

6.1.1.  By Value (Historic 2011-15)

6.1.2.  By Value ( Forecast 2016E-2021F)

6.2 Europe Bare Metal Stent Market , By Value

6.2.1.  By Value (Historic 2011-15)

6.2.2.  By Value ( Forecast 2016E-2021F)

6.3 Europe Drug Eluting Stent Market , By Value

6.3.1.  By Value (Historic 2011-15)

6.3.2.  By Value ( Forecast 2016E-2021F)

6.4 Europe Bioresorbable Stent Market , By Value

6.4.1   By Value (Historic 2012-15)

6.4.2.  By Value ( Forecast 2016E-2021F)

6.5 Europe Coronary Stent Market, By Country , By Percentage

6.5.1   In Percentage (2015)

6.5.2   In Percentage (2021F)

6.6 Europe Coronary Stent Market, By Country (UK,Germany(2011-2021F)

6.6.1   UK Coronary Stents Market, By Value

6.6.1.1 By Value (2011-2021F)

6.6.2. Germany Coronary Stents Market, By Value

6.6.2.1. By Value (2011-2021F)

 

7.  APAC Coronary Stent Market: An Analysis

7.1.  APAC Coronary Stent Market , By Value

7.1.1.  By Value (Historic 2011-15)

7.1.2.  By Value ( Forecast 2016E-2021F)

7.2.  APAC Bare Metal Stent Market , By Value

7.2.1.  By Value (Historic 2011-15)

7.2.2.  By Value ( Forecast 2016E-2021F)

7.3.  APAC  Drug Eluting Stent Market , By Value

7.3.1.  By Value (Historic 2011-15)

7.3.2.  By Value ( Forecast 2016E-2021F)

7.4.  APAC Bioresorbable  Stent Market , By Value

7.4.1.  By Value ( Forecast 2011-2021F)

7.5.  APAC Coronary Stent Market, By Country , By Percentage

7.5.1.  In Percentage (2015)

7.5.2.  In Percentage (2021F)

7.6.  APAC Coronary Stent Market, By Country (China, Japan , India) (2011-2021F)

7.6.1   China Coronary Stents Market, By Value

7.6.1.1 By Value (2011-2021F)

7.6.2   Japan Coronary Stents Market, By Value

7.6.2.1 By Value (2011-2021F)

7.6.3   India Coronary Stents Market, By Value

7.6.3.1 By Value (2011-2021F)

 

8. ROW Coronary Stent Market: An Analysis

8.1.  ROW  Coronary Stent Market , By Value

8.1.1.  By Value (Historic 2011-15)

8.1.2.  By Value ( Forecast 2016E-2021F)

8.2.  ROW Bare Metal Stent Market , By Value

8.2.1.  By Value (Historic 2011-15)

8.2.2.  By Value ( Forecast 2016E-2021F)

8.3.  ROW Drug Eluting Stent Market , By Value

8.3.1.  By Value (Historic 2011-15)

8.3.2.  By Value ( Forecast 2016E-2021F)

8.4.  ROW Bioresorbable  Stent Market , By Value

8.4.1.  By Value ( Forecast 2012-2021F)

8.5.  ROW Coronary Stent Market, By Country , By Percentage

8.5.1.  In Percentage (2015)

8.5.2.  In Percentage (2021F)

8.6.  ROW Coronary Stent Market, By Country (Brazil, UAE) (2011-2021F)

8.6.1   Brazil Coronary Stents Market, By Value

8.6.1.1. By Value (2011-2021F)

8.6.2 UAE Coronary Stents Market, By Value

8.6.2.1. By Value (2011-2021F)

 

9. Market Dynamics

9.1. Trends

9.2. Drivers

9.3. Challenges

 

10. Pricing Structure                                 

 

11. Policy and Regulatory Landscape                           

 

12. M&A and Licensing Route to Coronary Stent Market       

 

13. SWOT Analysis                         

 

14. Porter’s Five Forces Model                

 

15. Product Benchmarking   

                   

16. Company Profiling                   

16.1   Terumo Corporation 

16.2   Boston Scientific      

16.3   Stentys SA    

16.4   MicroPort  ScientificCorporation    

16.5.  Biotronik       

16.6   Elixir Medical Corporation    

16.7   Biosensors Inc.        

16.8   Medtronic     

16.9   Abbott Laboratories  

16.10  Kyoto Medical Planning           

List of Figures

Figure 1: Global Coronary Stent Market Size, By Value, 2011-2021F (USD Billion)

Figure 2: Number of Annual Deaths  Due to Cardiovascular Diseases

Figure 3: Life and Non Life Insurance Penetration in Select Countries 2015 in Percentage

Figure 4: Global Coronary Stent Market Segment Share 2015 In Percentage

Figure 5: Global Coronary Stent Market Segment Share 2021 In Percentage

Figure 6: Global Bare Metal Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 7: Global Bare Metal Stent  Market, By Value ,Forecast(2016E-2021F) in USD Billion

Figure 8: Global Drug Eluting Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 9: Global Drug Eluting Stent  Market  By Value , Forecast(2016E-2021F) in USD Billion

Figure 10: Global Bioresorbable Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 11: Global Bioresorbable Stent  Market  By Value , Forecast(2016E-2021F) in USD Million

Figure 12: Global Coronary Stent Market Region Share 2015 In Percentage

Figure 13: Global Coronary Stent Market Region Share 2021 In Percentage

Figure 14: North America  Coronary Stent  Market, By Value , Historic(2011-2015) in USD Billion

Figure 15: North America Coronary Stent  Market  By Value , Forecast (2016E-2021F) in USD Billion

Figure 16: Payment for Cardiology Services in USA

Figure 17: North America  Bare Metal Stent  Market, By Value , Historic(2011-2015) in USD Million

Figure 18: North America Bare Metal Stent  Market  By Value , Forecast(2016E-2021F) in USD Million

Figure 19: North America Drug Eluting Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 20: North America Drug Eluting Stent  Market  By Value , Forecast(2016E-2021F) in USD Billion

Figure 21: North America Bioresorbable Stent  Market  By Value , Forecast(2016E-2021F) in USD Million

Figure 22: North America  Coronary Stent Market, By Country – 2015(%)

Figure 23: North America  Coronary Stent Market, By Country  – 2021F(%)

Figure 24: USA Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion

Figure 25: USA Coronary Stent Market  By Value , Forecast(2016E-2021F)in USD Billion

Figure 26: Percentage of Population Suffering From Cardiovascular Disease in USA (2009-2012)

Figure 27: Direct and Indirect Costs  Associated With Major Heart Diseases  in USA (USD Billion)(2009-2012)

Figure 28: Canada Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 29: Canada Coronary Stent Market  By Value ,Forecast (2016E-2021F) in USD Million

Figure 30: Europe Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion

Figure 31: Europe Coronary Stent  Market  By Value , Forecast(2016E-2021F) in USD Billion

Figure 32: Cost of CVD in 2014 in some European Countries

Figure 33: Europe Bare Metal Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 34: Europe Bare Metal Stent  Market, By Value ,Forecast(2016E-2021F) in USD Million

Figure 35: Europe Drug Eluting Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 36: Europe Drug Eluting Stent  Market  By Value , Forecast(2016E-2021F) in USD Billion

Figure 37: Europe Bioresorbable Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 38: Europe Bioresorbable Stent  Market  By Value , Forecast(2016E-2021F) in USDMillion

Figure 39: Europe Coronary Stent  Market, By Country – 2015(%)

Figure 40: Europe Coronary Stent Market, By Country – 2021F(%)

Figure 41: UK Coronary Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 42: UK Coronary Stent Market  By Value , Forecast(2016E-2021F)in USD Million

Figure 43: Germany Coronary Stents  Market, By Value ,Historic(2011-2015) in USD Million

Figure 44: Germany Coronary Stents Market  By Value ,Forecast(2016E-2021F) in USD Million

Figure 45: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 46: Others Coronary Stent Market  By Value ,Forecast (2016E-2021F) in USD Million

Figure 47: APAC Coronary Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 48: APAC Coronary Stent Market  By Value ,Forecast (2016E-2021F) in USD Billion

Figure 49: APAC Bare Metal Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 50: APAC Bare Metal Stent  Market, By Value ,Forecast (2016E-2021F) in USD Million

Figure 51: APAC  Drug Eluting Stent  Market, By Value , Historic(2011-2015) in USDMillion

Figure 52: APAC Drug Eluting Stent  Market  By Value , Forecast (2016E-2021F) in USD Million

Figure 53: APAC Bioresorbable Stent  Market, By Value , Historic(2011-2015)in USD Million

Figure 54: APAC Bioresorbable Stent  Market  By Value , Forecast(2016E-2021F) in USDMillion

Figure 55: APAC Coronary Stent Market, By Country – 2015(%)

Figure 56: APAC Coronary Stent Market, By Country – 2021F(%)

Figure 57: China Coronary Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 58: China Coronary Stent Market  By Value ,Forecast(2016E-2021F) in USD Million

Figure 59: Japan Coronary Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 60: Japan Coronary Market  By Value , Forecast(2016E-2021F)in USD Million

Figure 61: India Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 62: India Coronary Stent Market  By Value ,Forecast(2016E-2021F) in USD Million

Figure 63: ROW Coronary Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 64: ROW Coronary Stent Market  By Value , Forecast(2016E-2021F)in USD Million

Figure 65: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 66: ROW Coronary Stent Market  By Value , Forecast(2016E-2021F)in USD Million

Figure 67: ROW Bare Metal Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 68: ROW Bare Metal Stent  Market, By Value ,Forecast(2016E-2021F) in USD Million

Figure 69: ROW Drug Eluting Stent  Market, By Value ,Historic(2011-2015) in USD Billion

Figure 70: ROW Drug Eluting Stent  Market  By Value , Forecast(2016E-2021F) in USDBillion

Figure 71: ROW Bioresorbable Stent  Market, By Value ,Historic(2011-2015) in USD Million

Figure 72: ROW Bioresorbable Stent  Market  By Value , Forecast(2016E-2021F) in USD Million

Figure 73: ROW Coronary Stent Market, By Country – 2015(%)

Figure 74: ROW Coronary Stent Market, By Country – 2021F(%)

Figure 75: Brazil Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 76: Brazil Coronary Stent Market  By Value ,Forecast(2016E-2021F) in USD Million

Figure 77: UAE Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 78: UAE Coronary Stent Market  By Value , Forecast(2016E-2021F)in USD Million

Figure 79: Causes of Death in UAE

Figure 80: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 81: Others Coronary Stent Market  By Value ,Forecast(2016E-2021F) in USD Million

Figure 82: Average Price of Bare-metal stents

Figure 83: Average Price of Drug Eluting stents

Figure 84: Cardiac And Vascular Business, By Segment-2015

Figure 85: Cardiac And Vascular Business, By Geography - 2015

Figure 86: Revenue, By Segment-2015 (in Percentage)

Figure 87: Revenue, By Geography - 2015

Figure 88: Revenue, By Segment-2015 (in Percentage)

Figure 89: Revenue, By Geography - 2015

Figure 90: Revenue, By Segment-2015(in Percentage)

Figure 91: Cardiac and Vascular Group Revenue, By Geography - 2015

Figure 92: Revenue, By Segment-2015 (in Percentage)

Figure 93: Overall Revenue,By Geography – 2015

 

List of Tables

Table 1: Number of Physicians in Cardiology in Canada in 2016

Table 2: Average Price of Bare-metal stents

Table 3: Average Price of Drug Eluting stents

Table 4: Cardio and Vascular Business Revenue By Segment (in USD Billion)

One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports